These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 7632763)

  • 1. Is technetium-99m the radioisotope of choice for radioimmunoscintigraphy?
    Hnatowich DJ
    J Nucl Biol Med (1991); 1994 Dec; 38(4 Suppl 1):22-32. PubMed ID: 7632763
    [No Abstract]   [Full Text] [Related]  

  • 2. Labeling of antibodies with technetium-99m.
    Griffiths GL; Hansen HJ; Goldenberg DM
    J Nucl Med; 1993 Sep; 34(9):1617-9. PubMed ID: 8257506
    [No Abstract]   [Full Text] [Related]  

  • 3. Fast and specific labeling of antibody fragments with multiple atoms of heavy metal radioisotopes.
    Trubetskoy VS; Torchilin VP
    Anal Biochem; 1995 Aug; 229(2):345-7. PubMed ID: 7485993
    [No Abstract]   [Full Text] [Related]  

  • 4. [Possibilities of the use of radioactively labeled metabolites of hemoglobin-bilirubin for testing liver function. 1. Labeling of bilirubin with 99m technetium].
    Kämpfer I; Blottner A; Schneider G; Deckart H
    Radiol Diagn (Berl); 1988; 29(3):471-6. PubMed ID: 3186964
    [No Abstract]   [Full Text] [Related]  

  • 5. Bifunctional NHS-BAT ester for antibody conjugation and stable technetium-99m labeling: conjugation chemistry, immunoreactivity and kit formulation.
    Eisenhut M; Lehmann WD; Becker W; Behr T; Elser H; Strittmatter W; Steinsträsser A; Baum RP; Valerius T; Repp R; Deo Y
    J Nucl Med; 1996 Feb; 37(2):362-70. PubMed ID: 8667077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strategies for labeling monoclonal antibodies and antibody-like molecules with technetium-99m.
    Delmon-Moingeon LI; Mahmood A; Davison A; Jones AG
    J Nucl Biol Med (1991); 1991; 35(1):47-59. PubMed ID: 1932176
    [No Abstract]   [Full Text] [Related]  

  • 7. [Antibody radiolabeling with technetium-99m].
    Perera A; Pérez C
    Rev Esp Med Nucl; 1998; 17(4):302-9. PubMed ID: 9721347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ascorbate plays a major role in labeling proteins with technetium-99m.
    Thakur ML
    J Nucl Med; 1994 Sep; 35(9):1566-8. PubMed ID: 8071714
    [No Abstract]   [Full Text] [Related]  

  • 9. 99mTc labeling of highly potent small peptides.
    Liu S; Edwards DS; Barrett JA
    Bioconjug Chem; 1997; 8(5):621-36. PubMed ID: 9327124
    [No Abstract]   [Full Text] [Related]  

  • 10. Letter: Visualisation of thrombi with technetium-99m urokinase.
    Lancet; 1976 Sep; 2(7985):572-3. PubMed ID: 60645
    [No Abstract]   [Full Text] [Related]  

  • 11. Tumor imaging with technetium-99m-labeled hydrazinonicotinamide-Fab' conjugates.
    Ultee ME; Bridger GJ; Abrams MJ; Longley CB; Burton CA; Larsen SK; Henson GW; Padmanabhan S; Gaul FE; Schwartz DA
    J Nucl Med; 1997 Jan; 38(1):133-8. PubMed ID: 8998167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correction: Technetium-99m low density lipoprotein radiolabeling procedure.
    Lees RS
    J Nucl Med; 1986 Aug; 27(8):1377. PubMed ID: 3734913
    [No Abstract]   [Full Text] [Related]  

  • 13. Technetium-99m labelling of the IOR CEA 1 monoclonal antibody: evaluation of different methods.
    Gano L; Fernandes C; Cantinho G; Santos AI; Pena H; Vieira R; Salgado L; Patrício L
    Nuklearmedizin; 1997 Sep; 36(6):205-12. PubMed ID: 9380538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relevance of basic technetium chemistry to nuclear medicine.
    Jones AG; Davison A
    J Nucl Med; 1982 Nov; 23(11):1041-3. PubMed ID: 7131086
    [No Abstract]   [Full Text] [Related]  

  • 15. Radiolabelling of monoclonal antibodies.
    Mather SJ; Ellison D
    Nucl Med Commun; 1994 Sep; 15(9):772-4. PubMed ID: 7816392
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of sequential reagent addition on technetium-99m red blood cell labeling efficiency using the UltraTag kit.
    Massler J; Mento C; Shodavaram S; Cason R; Das S; Wang TS; Van Heertum RL
    J Nucl Med Technol; 1997 Dec; 25(4):269-71. PubMed ID: 9438928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Progress in the exploitation of technecium 99m in nuclear medicine in 1976 (author's transl)].
    Vilcek S; Machán V
    Cesk Radiol; 1979 Jan; 33(1):59-64. PubMed ID: 427993
    [No Abstract]   [Full Text] [Related]  

  • 18. Stable one-step technetium-99m labeling of His-tagged recombinant proteins with a novel Tc(I)-carbonyl complex.
    Waibel R; Alberto R; Willuda J; Finnern R; Schibli R; Stichelberger A; Egli A; Abram U; Mach JP; Plückthun A; Schubiger PA
    Nat Biotechnol; 1999 Sep; 17(9):897-901. PubMed ID: 10471933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progress in research on ligands, nuclides and techniques for labeling monoclonal antibodies.
    Srivastava SC; Mease RC
    Int J Rad Appl Instrum B; 1991; 18(6):589-603. PubMed ID: 1743983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Granulocyte kinetics and methods of evaluating cell performance.
    Peters AM
    Nucl Med Commun; 1988 Oct; 9(10):687-92. PubMed ID: 3062506
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.